>>> US After Hours Summary: COUP +7%, BOBE +6% following earnings/guid

 Hours Summary: COUP +7%, BOBE +6% following earnings/guidance... SB -13%, SBSI -9%, FET -5% following offering news

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: COUP +6.6%, BOBE +5.6% (also continues to evaluate all options to create shareholder value and is working with J.P. Morgan to review and evaluate potential opportunities for value creation; no formal timeline for the completion of the review), KMI +1.4% (expects to generate $4.46 bln of distributable cash flow for 2017)

Companies trading higher in after hours in reaction to news: TXMD +18.5% (announces 'positive' top-line results from its pivotal phase 3 Replenish Trial of TX-001HR; trial met primary endpoints), ACHN +4.5% (light volume; announces data presented at American Society of Hematology Meeting demonstrate potential advantages of factor D inhibition for the treatment of complement alternative pathway-mediated diseases), NVLS +2.9% (CFO discloses the purchase of 24K shares), SIEN +2.7% (confirms receipt of FDA pre-market supplement approval for four new breast implant styles in both shaped and round as well as additional profile and sizing options for nine existing implant offerings), BLCM +2.1% (presents clinical results to date of BPX-501 pediatric program and provides regulatory update)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: N/A

Companies trading lower in after hours in reaction to news: SB -13.3% (to offer common stock), LXRX -8.7% (announces top-line results today from a Phase 2 clinical study of sotagliflozin conducted by Lexicon in collaboration with JDRF), SBSI -8.6% (announces an underwritten public offering of approx. $60 mln of its common stock), FET -5.2% (announces a registered underwritten public offering by the co & certain funds affiliated with SCF Partners and Tinicum; 3.5 mln shares are being offered by the co and 3.5 mln shares are being offered by the selling stockholders), TEVA -4% (names Dipankar Bhattacharjee as President and CEO, Global Generic Medicines Group, effective today; reaffirms FY16 forecast), ASUR -3.7% (announces public offering of common stock), RCII -3% (CFO Guy Constant resigns), STWD -2.8% (commences 17.8 mln common stock offering)